Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Chlorpromazine | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Chlorpromazine | hsa00040 | Pentose and glucuronate interconversions | 4.00E-02 | 1 | P15121 | AKR1B1 | More | | Chlorpromazine | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Chlorpromazine | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Chlorpromazine | hsa00190 | Oxidative phosphorylation | 2.29E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | | Chlorpromazine | hsa00230 | Purine metabolism | 4.60E-02 | 4 | Q13370, P36959, Q13956, P27707 | PDE3B, GMPR, PDE6H, DCK | More | | Chlorpromazine | hsa00240 | Pyrimidine metabolism | 4.50E-02 | 2 | P32320, P27707 | CDA, DCK | More | | Chlorpromazine | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | | Chlorpromazine | hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 4.77E-02 | 1 | Q7LGA3 | HS2ST1 | More | | Chlorpromazine | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Chlorpromazine | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Chlorpromazine | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Chlorpromazine | hsa00600 | Sphingolipid metabolism | 3.76E-02 | 1 | P15289 | ARSA | More | | Chlorpromazine | hsa00620 | Pyruvate metabolism | 3.90E-02 | 2 | P07195, P11766 | LDHB, ADH5 | More | | Chlorpromazine | hsa00670 | One carbon pool by folate | 3.99E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | | Chlorpromazine | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Chlorpromazine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Chlorpromazine | hsa00790 | Folate biosynthesis | 2.02E-02 | 1 | P15121 | AKR1B1 | More | | Chlorpromazine | hsa00920 | Sulfur metabolism | 3.01E-02 | 1 | O95571 | ETHE1 | More | | Chlorpromazine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 6.38E-04 | 3 | P78417, P09211, P11712 | GSTO1, GSTP1, CYP2C9 | More | | Chlorpromazine | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Chlorpromazine | hsa00983 | Drug metabolism - other enzymes | 1.70E-04 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Chlorpromazine | hsa01100 | Metabolic pathways | 3.95E-02 | 23 | Q9Y234, Q99707, P29218, P11310, P27707, Q13370, P36959, Q13956, P30043, Q02252, O60701, O14772, O95954, Q02318, P04406, O15466, P09960, Q9P2R7, Q9UHY7, P35573, Q13488, Q16718, Q02809 | LIPT1, MTR, IMPA1, ACADM, DCK, PDE3B, GMPR, PDE6H, BLVRB, ALDH6A1, UGDH, FPGT, FTCD, CYP27A1, GAPDH, ST8SIA5, LTA4H, SUCLA2, ENOPH1, AGL, TCIRG1, NDUFA5, PLOD1 | More | | Chlorpromazine | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Chlorpromazine | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | | Chlorpromazine | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa01522 | Endocrine resistance | 3.74E-04 | 6 | P14780, P22694, P04049, Q9UM47, P10415, Q13323 | MMP9, PRKACB, RAF1, NOTCH3, BCL2, BIK | More | | Chlorpromazine | hsa01524 | Platinum drug resistance | 4.45E-02 | 4 | P10415, Q13489, P78417, P43246 | BCL2, BIRC3, GSTO1, MSH2 | More | | Chlorpromazine | hsa02010 | ABC transporters | 1.99E-04 | 4 | P45844, P08183, Q8IZY2, Q99758 | ABCG1, ABCB1, ABCA7, ABCA3 | More | | Chlorpromazine | hsa03010 | Ribosome | 1.08E-04 | 11 | P62753, P25398, P32969, P40429, P62829, Q07020, P18077, P36578, P27635, P05386, P62249 | RPS6, RPS12, RPL9, RPL13A, RPL23, RPL18, RPL35A, RPL4, RPL10, RPLP1, RPS16 | More | | Chlorpromazine | hsa03013 | RNA transport | 1.12E-02 | 11 | P62826, P52298, O14893, P61326, Q7Z3B4, P35658, P63279, Q14152, O75822, P78345, Q9Y6A5 | RAN, NCBP2, GEMIN2, MAGOH, NUP54, NUP214, UBE2I, EIF3A, EIF3J, RPP38, TACC3 | More | | Chlorpromazine | hsa03015 | mRNA surveillance pathway | 3.62E-02 | 3 | O43148, P61326, P52298 | RNMT, MAGOH, NCBP2 | More | | Chlorpromazine | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | | Chlorpromazine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Chlorpromazine | hsa03040 | Spliceosome | 1.11E-07 | 18 | Q14562, O43143, O60508, P17844, O14776, P08579, O75940, P52298, P09651, Q15365, O75494, Q07955, Q01130, Q13243, P11142, O95777, O43447, P61326 | DHX8, DHX15, CDC40, DDX5, TCERG1, SNRPB2, SMNDC1, NCBP2, HNRNPA1, PCBP1, FUSIP1, SFRS1, SFRS2, SFRS5, HSPA8, LSM8, PPIH, MAGOH | More | | Chlorpromazine | hsa03050 | Proteasome | 5.53E-03 | 2 | P43686, P28070 | PSMC4, PSMB4 | More | | Chlorpromazine | hsa03060 | Protein export | 4.46E-03 | 2 | Q15070, O76094 | OXA1L, SRP72 | More | | Chlorpromazine | hsa03320 | PPAR signaling pathway | 2.89E-03 | 4 | Q6PCB7, O00767, Q9UNU6, Q02318 | SLC27A1, SCD, CYP8B1, CYP27A1 | More | | Chlorpromazine | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | | Chlorpromazine | hsa03460 | Fanconi anemia pathway | 3.70E-03 | 3 | Q9NPI8, O60673, Q9UNA4 | FANCF, REV3L, POLI | More | | Chlorpromazine | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04012 | ErbB signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04014 | Ras signaling pathway | 1.42E-03 | 10 | P04049, P31751, P20827, P49767, Q13009, P17252, Q15311, P0DP23, P62873, P19174 | RAF1, AKT2, EFNA1, VEGFC, TIAM1, PRKCA, RALBP1, CALM1, GNB1, PLCG1 | More | | Chlorpromazine | hsa04015 | Rap1 signaling pathway | 3.67E-04 | 12 | P04049, P20827, P49767, P06213, Q13009, O00522, Q08828, P51828, P31751, P0DP23, P17252, P19174 | RAF1, EFNA1, VEGFC, INSR, TIAM1, KRIT1, ADCY1, ADCY7, AKT2, CALM1, PRKCA, PLCG1 | More | | Chlorpromazine | hsa04020 | Calcium signaling pathway | 1.04E-06 | 11 | P27987, Q08828, Q13557, P17252, O15399, P19174, P61073, P0DP23, P51828, P23634, P49767 | ITPKB, ADCY1, CAMK2D, PRKCA, GRIN2D, PLCG1, CXCR4, CALM1, ADCY7, ATP2B4, VEGFC | More | | Chlorpromazine | hsa04022 | cGMP-PKG signaling pathway | 3.15E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04024 | cAMP signaling pathway | 1.25E-03 | 10 | Q08828, P51828, P31751, P0DP23, P23634, P04049, Q13557, Q13370, O15399, Q13009 | ADCY1, ADCY7, AKT2, CALM1, ATP2B4, RAF1, CAMK2D, PDE3B, GRIN2D, TIAM1 | More | | Chlorpromazine | hsa04062 | Chemokine signaling pathway | 9.36E-03 | 11 | P51684, Q8NHW4, P19174, P62873, Q08828, P51828, Q13009, P14598, P42224, P31751, P04049 | CCR6, CCL4L2, PLCG1, GNB1, ADCY1, ADCY7, TIAM1, NCF1, STAT1, AKT2, RAF1 | More | | Chlorpromazine | hsa04064 | NF-kappa B signaling pathway | 2.28E-04 | 9 | P10415, Q13489, P51617, P01584, P29965, P19174, O75293, Q8NHW4, Q9NQC7 | BCL2, BIRC3, IRAK1, IL1B, CD40LG, PLCG1, GADD45B, CCL4L2, CYLD | More | | Chlorpromazine | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04070 | Phosphatidylinositol signaling system | 5.66E-04 | 6 | P19174, P0DP23, P23743, P48426, P27987, P17252 | PLCG1, CALM1, DGKA, PIP4K2A, ITPKB, PRKCA | More | | Chlorpromazine | hsa04071 | Sphingolipid signaling pathway | 3.96E-08 | 12 | P04049, P17252, P21453, Q9H228, P01375, Q13510, Q13362, Q9BX95, Q16539, P10415, Q9UQC2, P01042 | RAF1, PRKCA, S1PR1, EDG8, TNF, ASAH1, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2, KNG1 | More | | Chlorpromazine | hsa04072 | Phospholipase D signaling pathway | 9.87E-03 | 9 | P04049, P31751, P19174, P17252, Q15438, Q08828, P51828, P23743, P00734 | RAF1, AKT2, PLCG1, PRKCA, PSCD1, ADCY1, ADCY7, DGKA, F2 | More | | Chlorpromazine | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | | Chlorpromazine | hsa04114 | Oocyte meiosis | 6.23E-03 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Chlorpromazine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Chlorpromazine | hsa04137 | Mitophagy - animal | 3.55E-04 | 4 | Q96CV9, Q9H1Y0, P18848, O43524 | OPTN, ATG5, ATF4, FOXO3 | More | | Chlorpromazine | hsa04140 | Autophagy - animal | 1.61E-02 | 8 | P31751, P04049, Q7L523, Q96RR4, O75460, P10415, Q96GC9, Q8TEV9 | AKT2, RAF1, RRAGA, CAMKK2, ERN1, BCL2, TMEM49, SMCR8 | More | | Chlorpromazine | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | | Chlorpromazine | hsa04144 | Endocytosis | 8.99E-03 | 12 | P11142, Q9H444, O43633, O75351, Q9NZZ3, Q15438, Q14161, P14784, Q96QK1, Q9UMY4, Q9Y5X3, Q9UNH7 | HSPA8, CHMP4B, CHMP2A, VPS4B, CHMP5, PSCD1, GIT2, IL2RB, VPS35, SNX12, SNX5, SNX6 | More | | Chlorpromazine | hsa04145 | Phagosome | 5.56E-03 | 8 | P60709, P63261, Q15075, Q15080, P14598, Q13509, Q13488, O60603 | ACTB, ACTG1, EEA1, NCF4, NCF1, TUBB3, TCIRG1, TLR2 | More | | Chlorpromazine | hsa04146 | Peroxisome | 3.03E-04 | 6 | O43933, O96011, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX11B, PEX3, CROT, ECI2, ACSL1 | More | | Chlorpromazine | hsa04150 | mTOR signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04151 | PI3K-Akt signaling pathway | 4.68E-03 | 18 | O43521, P27348, P20827, P49767, Q13362, P08238, P62873, P16144, P48551, P14784, P23458, P01568, P15336, P18848, P10415, P17252, Q16513, Q6ZUJ8 | BCL2L11, YWHAQ, EFNA1, VEGFC, PPP2R5C, HSP90AB1, GNB1, ITGB4, IFNAR2, IL2RB, JAK1, IFNA21, ATF2, ATF4, BCL2, PRKCA, PKN2, PIK3AP1 | More | | Chlorpromazine | hsa04210 | Apoptosis | 8.00E-05 | 8 | O76075, P07384, P01375, Q9NR28, Q16548, P60709, P63261, P04049 | DFFB, CAPN1, TNF, DIABLO, BCL2A1, ACTB, ACTG1, RAF1 | More | | Chlorpromazine | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | | Chlorpromazine | hsa04217 | Necroptosis | 1.49E-11 | 22 | P01375, P01568, P23458, P48023, Q13489, Q9NQC7, P42224, Q14765, P07900, P08238, P15104, P05141, P01584, P0C0S5, Q6FI13, Q99878, P10415, Q13557, Q9H444, O43633, Q9NZZ3, O75351 | TNF, IFNA21, JAK1, FASLG, BIRC3, CYLD, STAT1, STAT4, HSP90AA1, HSP90AB1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, H2AC14, BCL2, CAMK2D, CHMP4B, CHMP2A, CHMP5, VPS4B | More | | Chlorpromazine | hsa04218 | Cellular senescence | 2.49E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.46E-07 | 13 | P09493, P07550, Q08828, P51828, P22694, P31751, P18848, Q13362, P0DP23, Q13557, P17252, P10415, P23634 | TPM1, ADRB2, ADCY1, ADCY7, PRKACB, AKT2, ATF4, PPP2R5C, CALM1, CAMK2D, PRKCA, BCL2, ATP2B4 | More | | Chlorpromazine | hsa04270 | Vascular smooth muscle contraction | 2.32E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Chlorpromazine | hsa04360 | Axon guidance | 3.05E-04 | 9 | P61073, P16333, P20827, O95631, P17252, Q13557, P23528, P04049, P19174 | CXCR4, NCK1, EFNA1, NTN1, PRKCA, CAMK2D, CFL1, RAF1, PLCG1 | More | | Chlorpromazine | hsa04370 | VEGF signaling pathway | 2.77E-04 | 4 | P16298, Q05397, Q02750, P04049 | PPP3CB, PTK2, MAP2K1, RAF1 | More | | Chlorpromazine | hsa04371 | Apelin signaling pathway | 1.61E-02 | 8 | P62873, P31751, P04049, Q08828, P51828, Q13370, Q13485, P0DP23 | GNB1, AKT2, RAF1, ADCY1, ADCY7, PDE3B, SMAD4, CALM1 | More | | Chlorpromazine | hsa04380 | Osteoclast differentiation | 4.18E-02 | 7 | Q9NQC7, Q9UQC2, P23458, P42224, P01584, Q15080, P14598 | CYLD, GAB2, JAK1, STAT1, IL1B, NCF4, NCF1 | More | | Chlorpromazine | hsa04390 | Hippo signaling pathway | 2.80E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Chlorpromazine | hsa04510 | Focal adhesion | 1.26E-02 | 8 | P16144, O75369, Q15942, P17252, Q13489, P10415, P04049, P49767 | ITGB4, FLNB, ZYX, PRKCA, BIRC3, BCL2, RAF1, VEGFC | More | | Chlorpromazine | hsa04520 | Adherens junction | 1.58E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Chlorpromazine | hsa04530 | Tight junction | 6.83E-04 | 6 | P60709, P63261, P16989, P56750, Q14247, P60660 | ACTB, ACTG1, CSDA, CLDN17, CTTN, MYL6 | More | | Chlorpromazine | hsa04540 | Gap junction | 1.12E-02 | 6 | P17252, Q13509, P68371, Q08828, P51828, P04049 | PRKCA, TUBB3, TUBB2C, ADCY1, ADCY7, RAF1 | More | | Chlorpromazine | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 9.61E-03 | 4 | Q13873, P04049, Q02750, Q86SE9 | BMPR2, RAF1, MAP2K1, PCGF5 | More | | Chlorpromazine | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Chlorpromazine | hsa04611 | Platelet activation | 2.61E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Chlorpromazine | hsa04612 | Antigen processing and presentation | 1.07E-03 | 6 | Q14953, P26715, P26717, Q13241, P01732, P01375 | KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Chlorpromazine | hsa04613 | Neutrophil extracellular trap formation | 1.49E-11 | 24 | P04049, P11215, O60603, P05164, P08246, Q9UM07, Q13547, P04908, Q6FI13, Q93077, P58876, P62807, Q16778, O60814, P68431, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | RAF1, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P11215 | ITGAM | Integrin alpha-M | 0.706 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | O60603 | TLR2 | Toll-like receptor 2 | 0.783 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | O60603 | TLR2 | Toll-like receptor 2 | 0.783 | P22748 | CA4 | Carbonic anhydrase 4 | O60603 | TLR2 | Toll-like receptor 2 | 0.919 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P05164 | MPO | Myeloperoxidase | 0.897 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P05164 | MPO | Myeloperoxidase | 0.897 | P22748 | CA4 | Carbonic anhydrase 4 | P05164 | MPO | Myeloperoxidase | 0.826 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P08246 | ELA2 | Neutrophil elastase | 0.934 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P08246 | ELA2 | Neutrophil elastase | 0.934 | P22748 | CA4 | Carbonic anhydrase 4 | P08246 | ELA2 | Neutrophil elastase | 0.921 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.897 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.897 | P22748 | CA4 | Carbonic anhydrase 4 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.856 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.711 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P04908 | H2AC4; H2AC8 | Histone H2A type 1-B/E | 0.734 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.755 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.755 | P22748 | CA4 | Carbonic anhydrase 4 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.866 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.737 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P58876 | H2BC5 | Histone H2B type 1-D | 0.947 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q16778 | HIST2H2BE | Histone H2B type 2-E | 0.793 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | O60814 | H2BC12 | Histone H2B type 1-K | 0.72 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.913 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.839 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.839 | P22748 | CA4 | Carbonic anhydrase 4 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.951 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P20160 | AZU1 | Azurocidin | 0.863 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P20160 | AZU1 | Azurocidin | 0.863 | P22748 | CA4 | Carbonic anhydrase 4 | P20160 | AZU1 | Azurocidin | 0.747 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P08311 | CTSG | Cathepsin G | 0.826 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P08311 | CTSG | Cathepsin G | 0.826 | P22748 | CA4 | Carbonic anhydrase 4 | P08311 | CTSG | Cathepsin G | 0.717 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.832 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.832 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.753 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.753 | P22748 | CA4 | Carbonic anhydrase 4 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.81 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.751 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.751 | P22748 | CA4 | Carbonic anhydrase 4 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.826 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.815 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.815 | P22748 | CA4 | Carbonic anhydrase 4 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.895 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O43315 | AQP9 | Aquaporin-9 | -0.764 | P22748 | CA4 | Carbonic anhydrase 4 | O43315 | AQP9 | Aquaporin-9 | 0.771 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P22748 | CA4 | Carbonic anhydrase 4 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.767 |
| Chlorpromazine | hsa04620 | Toll-like receptor signaling pathway | 1.33E-02 | 5 | P51617, P01568, P31751, P42224, Q8NHW4 | IRAK1, IFNA21, AKT2, STAT1, CCL4L2 | More | | Chlorpromazine | hsa04621 | NOD-like receptor signaling pathway | 2.73E-04 | 15 | P01584, P08238, P23458, P42224, P01568, Q9H3M7, Q13489, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | IL1B, HSP90AB1, JAK1, STAT1, IFNA21, TXNIP, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | | Chlorpromazine | hsa04623 | Cytosolic DNA-sensing pathway | 4.25E-02 | 2 | P01568, Q8NHW4 | IFNA21, CCL4L2 | More | | Chlorpromazine | hsa04625 | C-type lectin receptor signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04630 | JAK-STAT signaling pathway | 1.77E-03 | 9 | P31751, P10415, P42224, P23458, P14784, P16871, Q13651, P04049, P01568 | AKT2, BCL2, STAT1, JAK1, IL2RB, IL7R, IL10RA, RAF1, IFNA21 | More | | Chlorpromazine | hsa04640 | Hematopoietic cell lineage | 2.82E-03 | 4 | P08514, P21926, P07766, P09564 | ITGA2B, CD9, CD3E, CD7 | More | | Chlorpromazine | hsa04650 | Natural killer cell mediated cytotoxicity | 5.84E-06 | 11 | P16298, P50591, P01375, P20963, Q02750, P04049, Q13241, P26718, P26717, Q14953, P26715 | PPP3CB, TNFSF10, TNF, CD247, MAP2K1, RAF1, KLRD1, KLRK1, KLRC2, KIR2DS5, KLRC1 | More | | Chlorpromazine | hsa04657 | IL-17 signaling pathway | 5.66E-05 | 10 | P07900, O00463, Q16539, P49841, P19875, P14780, Q9UJX4, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL2, MMP9, ANAPC5, LCN2, TNF, IL1B | More | | Chlorpromazine | hsa04660 | T cell receptor signaling pathway | 1.66E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04662 | B cell receptor signaling pathway | 2.13E-03 | 3 | P25963, P20023, P04049 | NFKBIA, CR2, RAF1 | More | | Chlorpromazine | hsa04664 | Fc epsilon RI signaling pathway | 1.16E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04666 | Fc gamma R-mediated phagocytosis | 1.47E-02 | 7 | P08575, P19174, P04049, P23528, Q9UQC2, P14598, P17252 | PTPRC, PLCG1, RAF1, CFL1, GAB2, NCF1, PRKCA | More | | Chlorpromazine | hsa04668 | TNF signaling pathway | 3.55E-02 | 4 | P01375, P18848, P19875, P14780 | TNF, ATF4, CXCL2, MMP9 | More | | Chlorpromazine | hsa04670 | Leukocyte transendothelial migration | 4.07E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Chlorpromazine | hsa04713 | Circadian entrainment | 5.61E-05 | 7 | O15399, P0DP23, Q13557, P17252, P62873, Q08828, P51828 | GRIN2D, CALM1, CAMK2D, PRKCA, GNB1, ADCY1, ADCY7 | More | | Chlorpromazine | hsa04714 | Thermogenesis | 3.66E-05 | 8 | Q16539, P15336, P60709, P63261, P33121, Q16718, O14521, P36542 | MAPK14, ATF2, ACTB, ACTG1, ACSL1, NDUFA5, SDHD, ATP5C1 | More | | Chlorpromazine | hsa04720 | Long-term potentiation | 1.22E-04 | 10 | P17252, Q13557, P16298, P0DP23, P51812, P18848, O15399, Q08828, Q02750, P04049 | PRKCA, CAMK2D, PPP3CB, CALM1, RPS6KA3, ATF4, GRIN2D, ADCY1, MAP2K1, RAF1 | More | | Chlorpromazine | hsa04722 | Neurotrophin signaling pathway | 7.10E-03 | 4 | P04049, P49841, O43524, P48023 | RAF1, GSK3B, FOXO3, FASLG | More | | Chlorpromazine | hsa04724 | Glutamatergic synapse | 5.91E-03 | 7 | P48058, O15399, Q08828, P51828, P17252, P62873, P15104 | GRIA4, GRIN2D, ADCY1, ADCY7, PRKCA, GNB1, GLUL | More | | Chlorpromazine | hsa04725 | Cholinergic synapse | 4.42E-04 | 8 | Q08828, P51828, P17252, P62873, P18848, Q13557, P31751, P10415 | ADCY1, ADCY7, PRKCA, GNB1, ATF4, CAMK2D, AKT2, BCL2 | More | | Chlorpromazine | hsa04726 | Serotonergic synapse | 1.33E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04727 | GABAergic synapse | 4.08E-02 | 5 | Q08828, P51828, P62873, P46459, P17252 | ADCY1, ADCY7, GNB1, NSF, PRKCA | More | | Chlorpromazine | hsa04730 | Long-term depression | 1.16E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04740 | Olfactory transduction | 5.88E-03 | 4 | P62873, Q9H255, Q13557, P0DP23 | GNB1, OR51E2, CAMK2D, CALM1 | More | | Chlorpromazine | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Chlorpromazine | hsa04744 | Phototransduction | 1.30E-05 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Chlorpromazine | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.32E-05 | 8 | P01584, Q08828, P51828, Q13557, P19174, P17252, P0DP23, P01042 | IL1B, ADCY1, ADCY7, CAMK2D, PLCG1, PRKCA, CALM1, KNG1 | More | | Chlorpromazine | hsa04810 | Regulation of actin cytoskeleton | 3.81E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04910 | Insulin signaling pathway | 2.51E-03 | 4 | P22694, P06737, P04049, P49841 | PRKACB, PYGL, RAF1, GSK3B | More | | Chlorpromazine | hsa04911 | Insulin secretion | 3.47E-02 | 4 | Q08828, P17252, P18848, Q13557 | ADCY1, PRKCA, ATF4, CAMK2D | More | | Chlorpromazine | hsa04912 | GnRH signaling pathway | 1.35E-02 | 6 | P17252, Q08828, P18848, Q13557, P0DP23, P04049 | PRKCA, ADCY1, ATF4, CAMK2D, CALM1, RAF1 | More | | Chlorpromazine | hsa04913 | Ovarian steroidogenesis | 2.45E-03 | 3 | P42330, P22694, P06213 | AKR1C3, PRKACB, INSR | More | | Chlorpromazine | hsa04914 | Progesterone-mediated oocyte maturation | 6.70E-04 | 11 | Q17RY0, Q08828, P51828, P31751, Q13370, Q9UJX4, Q9Y6D9, P08238, P51812, Q02750, P04049 | CPEB4, ADCY1, ADCY7, AKT2, PDE3B, ANAPC5, MAD1L1, HSP90AB1, RPS6KA3, MAP2K1, RAF1 | More | | Chlorpromazine | hsa04915 | Estrogen signaling pathway | 2.35E-03 | 10 | P04049, P18848, Q08828, P51828, P31751, P08238, P11142, P0DP23, Q15788, P10415 | RAF1, ATF4, ADCY1, ADCY7, AKT2, HSP90AB1, HSPA8, CALM1, NCOA1, BCL2 | More | | Chlorpromazine | hsa04916 | Melanogenesis | 1.33E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04917 | Prolactin signaling pathway | 6.63E-03 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04919 | Thyroid hormone signaling pathway | 6.15E-05 | 7 | P49841, P04049, P22694, P60709, P63261, O60244, Q9NVC6 | GSK3B, RAF1, PRKACB, ACTB, ACTG1, MED14, MED17 | More | | Chlorpromazine | hsa04921 | Oxytocin signaling pathway | 1.43E-04 | 4 | P04049, P60660, P60709, P63261 | RAF1, MYL6, ACTB, ACTG1 | More | | Chlorpromazine | hsa04923 | Regulation of lipolysis in adipocytes | 4.48E-03 | 5 | Q08828, P51828, P06213, Q13370, P31751 | ADCY1, ADCY7, INSR, PDE3B, AKT2 | More | | Chlorpromazine | hsa04924 | Renin secretion | 4.04E-02 | 2 | P22694, P07550 | PRKACB, ADRB2 | More | | Chlorpromazine | hsa04925 | Aldosterone synthesis and secretion | 6.45E-04 | 7 | P18848, Q08828, P51828, P0DP23, P17252, Q13557, P23634 | ATF4, ADCY1, ADCY7, CALM1, PRKCA, CAMK2D, ATP2B4 | More | | Chlorpromazine | hsa04926 | Relaxin signaling pathway | 6.24E-03 | 5 | P18848, P22694, P14780, P04049, P30679 | ATF4, PRKACB, MMP9, RAF1, GNA15 | More | | Chlorpromazine | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | | Chlorpromazine | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.99E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04929 | GnRH secretion | 4.98E-03 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa04930 | Type II diabetes mellitus | 3.14E-02 | 1 | P06213 | INSR | More | | Chlorpromazine | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Chlorpromazine | hsa04932 | Non-alcoholic fatty liver disease | 6.73E-05 | 9 | P01375, P49841, P18848, P48023, P01584, P13073, O15239, Q16718, O14521 | TNF, GSK3B, ATF4, FASLG, IL1B, COX4I1, NDUFA1, NDUFA5, SDHD | More | | Chlorpromazine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.04E-06 | 8 | Q13485, P01584, P42224, P10415, P31751, P49767, P17252, P19174 | SMAD4, IL1B, STAT1, BCL2, AKT2, VEGFC, PRKCA, PLCG1 | More | | Chlorpromazine | hsa04935 | Growth hormone synthesis, secretion and action | 1.77E-02 | 7 | P19174, Q08828, P51828, P04049, P17252, P31751, P42224 | PLCG1, ADCY1, ADCY7, RAF1, PRKCA, AKT2, STAT1 | More | | Chlorpromazine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Chlorpromazine | hsa04960 | Aldosterone-regulated sodium reabsorption | 3.14E-02 | 1 | P06213 | INSR | More | | Chlorpromazine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Chlorpromazine | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Chlorpromazine | hsa04970 | Salivary secretion | 9.40E-05 | 8 | P07550, Q08828, P51828, P22694, P23634, P17252, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, ATP2B4, PRKCA, CALM1, CAMP | More | | Chlorpromazine | hsa04971 | Gastric acid secretion | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Chlorpromazine | hsa04972 | Pancreatic secretion | 1.92E-03 | 5 | P23634, P17252, Q08828, P51828, P62491 | ATP2B4, PRKCA, ADCY1, ADCY7, RAB11A | More | | Chlorpromazine | hsa04976 | Bile secretion | 1.67E-03 | 3 | O43315, P22694, P08183 | AQP9, PRKACB, ABCB1 | More | | Chlorpromazine | hsa05012 | Parkinson disease | 2.53E-02 | 5 | O15239, P13073, P05141, P18848, Q13557 | NDUFA1, COX4I1, SLC25A5, ATF4, CAMK2D | More | | Chlorpromazine | hsa05014 | Amyotrophic lateral sclerosis | 2.98E-02 | 3 | P36542, P60709, P63261 | ATP5C1, ACTB, ACTG1 | More | | Chlorpromazine | hsa05016 | Huntington disease | 3.21E-02 | 5 | O15239, P13073, P30876, P62487, P05141 | NDUFA1, COX4I1, POLR2B, POLR2G, SLC25A5 | More | | Chlorpromazine | hsa05017 | Spinocerebellar ataxia | 3.80E-03 | 8 | P17252, O75460, Q8TB72, O15399, P31751, P28070, P43686, O00232 | PRKCA, ERN1, PUM2, GRIN2D, AKT2, PSMB4, PSMC4, PSMD12 | More | | Chlorpromazine | hsa05020 | Prion disease | 3.73E-04 | 11 | P13591, P01584, P11142, O15239, Q16718, O14521, P13073, P18848, P05141, P49841, Q16539 | NCAM1, IL1B, HSPA8, NDUFA1, NDUFA5, SDHD, COX4I1, ATF4, SLC25A5, GSK3B, MAPK14 | More | | Chlorpromazine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.47E-03 | 12 | P49841, O15239, Q16718, O14521, P13073, P18848, Q13561, P05141, Q16539, P01584, Q08752, Q13557 | GSK3B, NDUFA1, NDUFA5, SDHD, COX4I1, ATF4, DCTN2, SLC25A5, MAPK14, IL1B, PPID, CAMK2D | More | | Chlorpromazine | hsa05031 | Amphetamine addiction | 3.62E-03 | 7 | O15399, P0DP23, Q13557, P22694, P18848, P17252, Q13547 | GRIN2D, CALM1, CAMK2D, PRKACB, ATF4, PRKCA, HDAC1 | More | | Chlorpromazine | hsa05032 | Morphine addiction | 4.08E-02 | 5 | Q08828, P51828, P62873, Q13370, P17252 | ADCY1, ADCY7, GNB1, PDE3B, PRKCA | More | | Chlorpromazine | hsa05034 | Alcoholism | 1.81E-06 | 8 | Q13547, P04049, Q93077, P58876, P62807, Q16778, O60814, P68431 | HDAC1, RAF1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Chlorpromazine | hsa05100 | Bacterial invasion of epithelial cells | 7.49E-04 | 5 | Q14141, P60709, P63261, Q05397, Q96JJ3 | SEPT6, ACTB, ACTG1, PTK2, ELMO2 | More | | Chlorpromazine | hsa05110 | Vibrio cholerae infection | 3.95E-03 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Chlorpromazine | hsa05131 | Shigellosis | 6.67E-04 | 12 | P01375, O00463, Q04759, Q9UDY8, Q9H1Y0, P60709, P63261, P20810, O43524, P07384, P10415, Q96A32 | TNF, TRAF5, PRKCQ, MALT1, ATG5, ACTB, ACTG1, CAST, FOXO3, CAPN1, BCL2, MYLPF | More | | Chlorpromazine | hsa05132 | Salmonella infection | 2.26E-04 | 14 | P51617, P01584, P08238, P04049, Q96RF0, Q13489, P10415, P08575, O75369, Q13561, Q13509, P68371, P49754, Q9NP90 | IRAK1, IL1B, HSP90AB1, RAF1, SNAG1, BIRC3, BCL2, PTPRC, FLNB, DCTN2, TUBB3, TUBB2C, VPS41, RAB9B | More | | Chlorpromazine | hsa05133 | Pertussis | 6.00E-05 | 6 | P0DP23, P01584, P23528, P09871, P0C0L4, P51617 | CALM1, IL1B, CFL1, C1S, C4A, IRAK1 | More | | Chlorpromazine | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | | Chlorpromazine | hsa05135 | Yersinia infection | 6.16E-04 | 7 | P60709, P63261, Q05397, Q16513, P51812, Q02750, Q96JJ3 | ACTB, ACTG1, PTK2, PKN2, RPS6KA3, MAP2K1, ELMO2 | More | | Chlorpromazine | hsa05140 | Leishmaniasis | 2.58E-02 | 5 | P14598, O60603, P25963, P29350, Q15080 | NCF1, TLR2, NFKBIA, PTPN6, NCF4 | More | | Chlorpromazine | hsa05143 | African trypanosomiasis | 1.93E-04 | 7 | P01375, P01584, P69905, P68871, P48023, P17252, P01042 | TNF, IL1B, HBA2, HBB, FASLG, PRKCA, KNG1 | More | | Chlorpromazine | hsa05144 | Malaria | 6.73E-06 | 6 | P69905, P68871, O60603, P01375, P35443, P26718 | HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | | Chlorpromazine | hsa05145 | Toxoplasmosis | 5.28E-05 | 9 | P51617, P10415, Q13489, P23458, P42224, P31751, P11142, P29965, Q13651 | IRAK1, BCL2, BIRC3, JAK1, STAT1, AKT2, HSPA8, CD40LG, IL10RA | More | | Chlorpromazine | hsa05146 | Amoebiasis | 2.41E-02 | 4 | P19875, P01375, P30679, P22694 | CXCL2, TNF, GNA15, PRKACB | More | | Chlorpromazine | hsa05150 | Staphylococcus aureus infection | 8.69E-04 | 5 | P21730, P21462, O75015, P12838, P49913 | C5AR1, FPR1, FCGR3B, DEFA4, CAMP | More | | Chlorpromazine | hsa05152 | Tuberculosis | 1.17E-03 | 8 | P04049, O75015, P48382, O60603, P01375, P10415, P49913, Q9UDY8 | RAF1, FCGR3B, RFX5, TLR2, TNF, BCL2, CAMP, MALT1 | More | | Chlorpromazine | hsa05160 | Hepatitis C | 1.40E-03 | 5 | P60033, P04049, P49841, P01375, P48023 | CD81, RAF1, GSK3B, TNF, FASLG | More | | Chlorpromazine | hsa05161 | Hepatitis B | 2.85E-05 | 11 | P17252, P04049, P18848, P23458, Q13485, P31751, P10415, P27348, P01568, P42224, P51617 | PRKCA, RAF1, ATF4, JAK1, SMAD4, AKT2, BCL2, YWHAQ, IFNA21, STAT1, IRAK1 | More | | Chlorpromazine | hsa05162 | Measles | 2.45E-05 | 10 | P51617, P01568, P23458, P42224, P14784, P31751, P11142, P01584, Q9NP90, P10415 | IRAK1, IFNA21, JAK1, STAT1, IL2RB, AKT2, HSPA8, IL1B, RAB9B, BCL2 | More | | Chlorpromazine | hsa05163 | Human cytomegalovirus infection | 2.33E-03 | 15 | P31751, P04049, P62873, P0DP23, Q8NHW4, Q08828, P51828, P23458, P01584, P61073, P17252, Q13651, P18848, P61769, P01568 | AKT2, RAF1, GNB1, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, CXCR4, PRKCA, IL10RA, ATF4, B2M, IFNA21 | More | | Chlorpromazine | hsa05164 | Influenza A | 8.97E-04 | 4 | P48551, P04049, P60709, P63261 | IFNAR2, RAF1, ACTB, ACTG1 | More | | Chlorpromazine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.15E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05168 | Herpes simplex virus 1 infection | 2.45E-05 | 18 | P01568, P01584, Q9UBU9, P23458, P42224, Q07955, Q01130, Q13243, Q13489, P51617, P61769, P31751, Q13398, Q6P280, Q03923, Q9UDV6, P10415, Q14232 | IFNA21, IL1B, NXF1, JAK1, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, IRAK1, B2M, AKT2, ZNF211, ZNF529, ZNF85, ZNF212, BCL2, EIF2B1 | More | | Chlorpromazine | hsa05170 | Human immunodeficiency virus 1 infection | 1.46E-05 | 13 | P31751, P04049, P62873, P0DP23, P61073, P17252, P61769, P01568, P51617, P19174, P23528, P10415, Q9Y6Q5 | AKT2, RAF1, GNB1, CALM1, CXCR4, PRKCA, B2M, IFNA21, IRAK1, PLCG1, CFL1, BCL2, AP1M2 | More | | Chlorpromazine | hsa05171 | Coronavirus disease - COVID-19 | 6.98E-05 | 12 | P01584, P62753, P25398, P62249, P40429, P36578, P32969, P27635, Q07020, P18077, P05386, P62829 | IL1B, RPS6, RPS12, RPS16, RPL13A, RPL4, RPL9, RPL10, RPL18, RPL35A, RPLP1, RPL23 | More | | Chlorpromazine | hsa05200 | Pathways in cancer | 4.30E-09 | 28 | P23458, P08238, P42224, P19174, Q15311, P17252, P43246, Q13485, P14923, P10415, Q13489, P49767, P31751, Q08828, P51828, P62873, P61073, P78417, O75293, Q15788, P0DP23, Q13557, O43521, P01568, P14784, P16871, P00734, P01042 | JAK1, HSP90AB1, STAT1, PLCG1, RALBP1, PRKCA, MSH2, SMAD4, JUP, BCL2, BIRC3, VEGFC, AKT2, ADCY1, ADCY7, GNB1, CXCR4, GSTO1, GADD45B, NCOA1, CALM1, CAMK2D, BCL2L11, IFNA21, IL2RB, IL7R, F2, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP23 | CALM1 | Calmodulin-1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.822 | P0DP24 | CALM2 | Calmodulin-2 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.738 | P0DP23 | CALM1 | Calmodulin-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP25 | CALM3 | Calmodulin-3 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP25 | CALM3 | Calmodulin-3 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP25 | CALM3 | Calmodulin-3 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP24 | CALM2 | Calmodulin-2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP23 | CALM1 | Calmodulin-1 | Q15311 | RALBP1 | RalA-binding protein 1 | 0.858 | P0DP23 | CALM1 | Calmodulin-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP25 | CALM3 | Calmodulin-3 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP24 | CALM2 | Calmodulin-2 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP23 | CALM1 | Calmodulin-1 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP25 | CALM3 | Calmodulin-3 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP24 | CALM2 | Calmodulin-2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP23 | CALM1 | Calmodulin-1 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP25 | CALM3 | Calmodulin-3 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP24 | CALM2 | Calmodulin-2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP23 | CALM1 | Calmodulin-1 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP25 | CALM3 | Calmodulin-3 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP23 | CALM1 | Calmodulin-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP25 | CALM3 | Calmodulin-3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP24 | CALM2 | Calmodulin-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP23 | CALM1 | Calmodulin-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP25 | CALM3 | Calmodulin-3 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP24 | CALM2 | Calmodulin-2 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | P0DP23 | CALM1 | Calmodulin-1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.725 | P0DP24 | CALM2 | Calmodulin-2 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.711 | P0DP23 | CALM1 | Calmodulin-1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.719 | P0DP23 | CALM1 | Calmodulin-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP25 | CALM3 | Calmodulin-3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.759 | P0DP23 | CALM1 | Calmodulin-1 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP25 | CALM3 | Calmodulin-3 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP24 | CALM2 | Calmodulin-2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP23 | CALM1 | Calmodulin-1 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP25 | CALM3 | Calmodulin-3 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.731 | P0DP23 | CALM1 | Calmodulin-1 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP25 | CALM3 | Calmodulin-3 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.786 | P0DP24 | CALM2 | Calmodulin-2 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.75 | P0DP23 | CALM1 | Calmodulin-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP25 | CALM3 | Calmodulin-3 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP25 | CALM3 | Calmodulin-3 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP24 | CALM2 | Calmodulin-2 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP23 | CALM1 | Calmodulin-1 | P16871 | IL7R | Interleukin-7 receptor subunit alpha | 0.718 | P0DP23 | CALM1 | Calmodulin-1 | P00734 | F2 | Prothrombin | -0.738 | P0DP23 | CALM1 | Calmodulin-1 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP25 | CALM3 | Calmodulin-3 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP24 | CALM2 | Calmodulin-2 | P01042 | KNG1 | Kininogen-1 | -0.71 |
| Chlorpromazine | hsa05202 | Transcriptional misregulation in cancer | 1.62E-03 | 15 | Q15532, P41732, P14780, P27930, P14923, Q16548, P11215, Q13077, O15550, P35226, P05164, P08246, Q13547, P12980, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, ITGAM, TRAF1, UTX, BMI1, MPO, ELA2, HDAC1, LYL1, GADD45A | More | | Chlorpromazine | hsa05203 | Viral carcinogenesis | 1.22E-03 | 6 | Q13547, Q15283, P58876, P62807, Q16778, O60814 | HDAC1, RASA2, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | | Chlorpromazine | hsa05204 | Chemical carcinogenesis | 4.02E-05 | 5 | P00325, P09211, P78417, P11712, P33260 | ADH1B, GSTP1, GSTO1, CYP2C9, CYP2C18 | More | | Chlorpromazine | hsa05205 | Proteoglycans in cancer | 1.09E-02 | 6 | P04049, P14780, P01375, P23588, Q13635, P22694 | RAF1, MMP9, TNF, EIF4B, PTCH1, PRKACB | More | | Chlorpromazine | hsa05206 | MicroRNAs in cancer | 4.38E-03 | 3 | P15311, P63279, P04049 | VIL2, UBE2I, RAF1 | More | | Chlorpromazine | hsa05210 | Colorectal cancer | 1.66E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05211 | Renal cell carcinoma | 1.16E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05212 | Pancreatic cancer | 1.15E-03 | 7 | P31751, P04049, Q15311, P23458, P42224, Q13485, O75293 | AKT2, RAF1, RALBP1, JAK1, STAT1, SMAD4, GADD45B | More | | Chlorpromazine | hsa05213 | Endometrial cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05214 | Glioma | 3.96E-06 | 7 | P0DP23, Q13557, P17252, P04049, P31751, P19174, O75293 | CALM1, CAMK2D, PRKCA, RAF1, AKT2, PLCG1, GADD45B | More | | Chlorpromazine | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05218 | Melanoma | 6.63E-03 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05219 | Bladder cancer | 4.98E-03 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05220 | Chronic myeloid leukemia | 9.95E-03 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05221 | Acute myeloid leukemia | 8.29E-03 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05223 | Non-small cell lung cancer | 6.63E-03 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05224 | Breast cancer | 1.49E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05225 | Hepatocellular carcinoma | 2.85E-03 | 3 | P04049, P60709, P63261 | RAF1, ACTB, ACTG1 | More | | Chlorpromazine | hsa05226 | Gastric cancer | 8.29E-03 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05230 | Central carbon metabolism in cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05231 | Choline metabolism in cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.66E-02 | 1 | P04049 | RAF1 | More | | Chlorpromazine | hsa05321 | Inflammatory bowel disease | 1.91E-02 | 3 | P01375, Q14765, Q9UL17 | TNF, STAT4, TBX21 | More | | Chlorpromazine | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 7 | P09871, Q93077, P58876, P62807, Q16778, O60814, P68431 | C1S, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Chlorpromazine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Chlorpromazine | hsa05332 | Graft-versus-host disease | 7.27E-04 | 4 | P48023, P01375, P26715, Q13241 | FASLG, TNF, KLRC1, KLRD1 | More | | Chlorpromazine | hsa05340 | Primary immunodeficiency | 2.68E-02 | 2 | P11912, P07766 | CD79A, CD3E | More | | Chlorpromazine | hsa05410 | Hypertrophic cardiomyopathy | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Chlorpromazine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 3.44E-03 | 3 | P54284, P60709, P63261 | CACNB3, ACTB, ACTG1 | More | | Chlorpromazine | hsa05414 | Dilated cardiomyopathy | 1.73E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Chlorpromazine | hsa05415 | Diabetic cardiomyopathy | 1.02E-03 | 8 | P05141, O15239, Q16718, O14521, P13073, Q16539, P49841, Q13557 | SLC25A5, NDUFA1, NDUFA5, SDHD, COX4I1, MAPK14, GSK3B, CAMK2D | More | | Chlorpromazine | hsa05416 | Viral myocarditis | 8.96E-03 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Chlorpromazine | hsa05418 | Fluid shear stress and atherosclerosis | 3.64E-03 | 8 | P14598, P78417, P60709, P63261, P10415, P0DP23, P08238, Q92974 | NCF1, GSTO1, ACTB, ACTG1, BCL2, CALM1, HSP90AB1, ARHGEF2 | More | | |